Goldman Sachs Group »

Beam Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 484k 27.22
2023-09-30 $11M 462k 24.05
2023-06-30 $23M 726k 31.93
2023-03-31 $20M 658k 30.62
2022-12-31 $40M 1.0M 39.11
2022-06-30 $37M 954k 38.71
2022-03-31 $48M 829k 57.30
2021-12-31 $78M 974k 79.69
2021-09-30 $91M 1.0M 87.01
2021-03-31 $59M 734k 80.04
2020-12-31 $69M 841k 81.64
2020-09-30 $7.7M 311k 24.62
2020-06-30 $8.8M 315k 28.00